Request for Covid-19 Impact Assessment of this Report

Medical Devices

World Implantable Medical Devices Market by Product (Orthopedic Implants, Dental Implants, Breast Implants, Cardiovascular Implants, Intraocular Lens, and Other Implants) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ALL144258
  • 208 Pages
  • December 2016
  • Medical Devices
Download Sample    Get Discount   
 

An implant is a medical device that is surgically transplanted in the body to replace or support damaged body organs, enhance their functionalities, or detect flaws in functioning of organs. Medical devices can be placed either permanently or temporarily in the body, and can be removed when they are time-worned. These implantable devices are composed of bones, tissues, skin, ceramics, metals, and other natural materials.

The global implantable medical devices market was valued at $72,265 million in 2015, and is estimated to reach $116,300 million by 2022, registering a CAGR of 7.1% during the forecast period. The market is driven by factors such as rise in prevalence of chronic diseases and rapid increase in geriatric population. Moreover, increased awareness among individuals and rapid technological advancements in the medical implants sector fuel the market growth. However, high cost of implantation and dearth of skilled workforce hamper the market growth. Even then, this market is poised to grow at a CAGR of 10.7% from 2016 to 2022 (in terms of volume).

The global implantable medical devices market is segmented based on product type and geography. Based on product type, the market is categorized into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses, and other implants. The orthopedic implants segment contributed the highest revenue to the global market in 2015, owing to the large pool of patients undergoing orthopedic implants due to hyperactive lifestyle, unhealthy food habits, rise in geriatric population, and advancements in medical technologies. The other implants category was the fastest growing segment in 2015, due to increase in prevalence of neurological diseases, craniomaxillofacial deformities, and eye disorders; increase in the rate of cosmetic surgeries; and rise in geriatric population.

The market is segmented on the basis of four regions, namely North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share (nearly half) in the global implantable medical devices market in 2015 due to advancements in implantable medical devices and increase in prevalence of chronic diseases.

The Asia-Pacific region is expected to grow at the highest CAGR of 9.1% during the forecast period. The developing countries in the Asia-Pacific region, such as China and India, provide significant growth opportunities to market players, owing to the large population base and increase in awareness about the benefits of medical implants. Moreover, the report provides comprehensive analyses of the key players operating in the implantable medical devices market.

KEY BENEFITS

  • The study provides in-depth analyses of the global implantable medical devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis for the period of 2014‐2022 to enable stakeholders to capitalize on the prevailing opportunities in the industry.
  • Extensive analysis of the global market helps in understanding the different types of devices used in the treatment of chronic diseases and other cardiac conditions.
  • Competitive intelligence of market players highlights the business practices and trends across various regions.

KEY MARKET SEGMENTS

The global implantable medical devices market is segmented based on product type and geography.

By Product

  • Orthopedic Implants

    • Spinal Implants
    • Reconstructive Joint Replacement

  • Dental Implants
  • Breast Implants
  • Cardiovascular Implants
  • Intraocular Lens
  • Other Implants

By Region

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • UK
    • France
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • Rest of Asia-Pacific

  • LAMEA

    • Latin America
    • Middle East
    • Africa

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • CONMED Corporation
  • Globus Medical, Inc.
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic plc
  • NuVasive, Inc.
  • Smith & Nephew plc
  • St. Jude Medical, Inc.
  • Institut Straumann AG.
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report, but can be included on request)

  • Dentsply Sirona Inc.
  • GC Aesthetics plc
  • Allergan Inc.
  • Sientra Inc.
  • Danaher Corporation
  • 3M Company
  • Polytech Health & Aesthetics GmbH
  • B. Braun Melsungen AG
  • Elixir Medical Corporation
  • Microport Scientific Corporation
  • STENTYS S.A.
  • Terumo Corporation

Chapter: 1. INTRODUCTION

1.1. Report description

1.2. Key benefits

1.3. Key market segments

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

Chapter: 2. EXECUTIVE SUMMARY

2.1. Key findings of the study

2.2. CXO perspective

Chapter: 3. MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. Porters five forces analysis

3.3.1. Bargaining power of the suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of new entrants

3.3.4. High intensity of rivalry

3.3.5. Threat of substitutes

3.4. Top Player Positioning, 2015

3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Growing elderly population and rise in prevalence of chronic diseases

3.5.1.2. Technological advancements in the field of implantable medical devices

3.5.1.3. Global rise in acceptance of implantable medical devices

3.5.1.4. Improvement of healthcare infrastructure in developing countries

3.5.1.5. Better insurance and reimbursement

3.5.1.6. Increasing government focus on funding R&D initiatives

3.5.1.7. Rising number of FDA approvals for performing clinical trials to benefit the market

3.5.2. Restraints

3.5.2.1. High cost of treatment associated with implantable medical devices

3.5.2.2. Stringent approval process as these are highly specialized devices

3.5.3. Opportunities

3.5.3.1. Huge market opportunities in the APAC region and developing countries

3.5.3.2. Increasing awareness amongst patients and increasing preference for a better quality of life

3.5.3.3. Increase in development of minimally invasive and non-surgical procedures

Chapter: 4. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Orthopedic implants

4.2.1. Key market trends

4.2.2. Key growth factors and opportunities

4.2.3. Market size and forecast

4.2.4. Reconstructive joint replacements market size and forecast

4.2.5. Spinal implants market size and forecast

4.3. Cardiovascular implants

4.3.1. Key market trends

4.3.2. Key growth factors and opportunities

4.3.3. Market size and forecast

4.4. Intraocular lenses

4.4.1. Key market trends

4.4.2. Key growth factors and opportunities

4.4.3. Market size and forecast

4.5. Dental implants

4.5.1. Key market trends

4.5.2. Key growth factors and opportunities

4.5.3. Market size and forecast

4.6. Breast implants

4.6.1. Key market trends

4.6.2. Key growth factors and opportunities

4.6.3. Market size and forecast

4.7. Other implants

4.7.1. Key market trends

4.7.2. Key growth factors and opportunities

4.7.3. Market size and forecast

Chapter: 5. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION

5.1. Overview

5.1.1. Market size and forecast

5.2. North America

5.2.1. Key market trends

5.2.2. Key growth factors and opportunities

5.2.3. Market size and forecast

5.2.4. U.S. market size and forecast

5.2.5. Canada market size and forecast

5.2.6. Mexico market size and forecast

5.3. Europe

5.3.1. Key market trends

5.3.2. Key growth factors and opportunities

5.3.3. Market size and forecast

5.3.4. Germany market size and forecast

5.3.5. France market size and forecast

5.3.6. UK market size and forecast

5.3.7. Rest of Europe market size and forecast

5.4. Asia-Pacific

5.4.1. Key market trends

5.4.2. Key growth factors and opportunities

5.4.3. Market size and forecast

5.4.4. Japan market size and forecast

5.4.5. China market size and forecast

5.4.6. India market size and forecast

5.4.7. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends

5.5.2. Key growth factors and opportunities

5.5.3. Market size and forecast

5.5.4. Latin America market size and forecast

5.5.5. Middle East market size and forecast

5.5.6. Africa market size and forecast

Chapter: 6. COMPANY PROFILES

6.1. Abbott Laboratories

6.1.1. Company overview

6.1.2. Operating business segments

6.1.3. Business performance

6.1.4. Key strategic moves & developments

6.1.5. SWOT analysis

6.2. Biotronik SE & Co. KG

6.2.1. Company overview

6.2.2. Operating business segments

6.2.3. Key strategic moves & developments

6.2.4. SWOT analysis

6.3. Boston Scientific Corporation

6.3.1. Company overview

6.3.2. Operating business segments

6.3.3. Business performance

6.3.4. Key strategic moves & developments

6.3.5. SWOT analysis

6.4. C. R. Bard, Inc.

6.4.1. Company overview

6.4.2. Operating business segments

6.4.3. Business performance

6.4.4. Key strategic moves & developments

6.4.5. SWOT analysis

6.5. Cardinal Health, Inc.

6.5.1. Company overview

6.5.2. Operating business segments

6.5.3. Business performance

6.5.4. Key strategic moves & developments

6.5.5. SWOT analysis

6.6. Conmed Corporation

6.6.1. Company overview

6.6.2. Operating business segments

6.6.3. Business performance

6.6.4. SWOT analysis

6.7. Globus Medical, Inc.

6.7.1. Company overview

6.7.2. Operating business segments

6.7.3. Business performance

6.7.4. Key strategic moves & developments

6.7.5. SWOT analysis

6.8. Integra Lifesciences Holdings Corporation

6.8.1. Company overview

6.8.2. Operating business segments

6.8.3. Business performance

6.8.4. Key strategic moves & developments

6.8.5. SWOT analysis

6.9. Johnson & Johnson

6.9.1. Company overview

6.9.2. Operating business segments

6.9.3. Business performance

6.9.4. Key strategic moves & developments

6.9.5. SWOT analysis

6.10. LivaNova PLC

6.10.1. Company overview

6.10.2. Operating business segments

6.10.3. Business performance

6.10.4. Key strategic moves & developments

6.10.5. SWOT analysis

6.11. Medtronic plc

6.11.1. Company overview

6.11.2. Operating business segments

6.11.3. Business performance

6.11.4. Key strategic moves & developments

6.11.5. SWOT analysis

6.12. Nuvasive, Inc.

6.12.1. Company overview

6.12.2. Operating business segments

6.12.3. Business performance

6.12.4. Key strategic moves & developments

6.12.5. SWOT analysis

6.13. Smith & Nephew Plc

6.13.1. Company overview

6.13.2. Operating business segments

6.13.3. Business performance

6.13.4. Key strategic moves & developments

6.13.5. SWOT analysis

6.14. St. Jude Medical, Inc.

6.14.1. Company overview

6.14.2. Operating business segments

6.14.3. Business performance

6.14.4. Key strategic moves & developments

6.14.5. SWOT analysis

6.15. Institut Straumann AG.

6.15.1. Company overview

6.15.2. Business performance

6.15.3. Key strategic moves & developments

6.15.4. SWOT analysis

6.16. Stryker Corporation

6.16.1. Company overview

6.16.2. Operating business segments

6.16.3. Business performance

6.16.4. Key strategic moves & developments

6.16.5. SWOT analysis

6.17. Wright Medical Group N.V.

6.17.1. Company overview

6.17.2. Operating business segments

6.17.3. Business performance

6.17.4. Key strategic moves & developments

6.17.5. SWOT analysis

6.18. Zimmer Biomet Holdings, Inc.

6.18.1. Company overview

6.18.2. Operating business segments

6.18.3. Business performance

6.18.4. Key strategic moves & developments

6.18.5. SWOT analysis

List of Tables

TABLE 1. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022

TABLE 2. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT (THOUSAND UNITS), 2014-2022

TABLE 3. WORLD ORTHOPEDIC IMPLANTS MARKET, BY TYPE ($MILLION), 2014-2022

TABLE 4. WORLD ORTHOPEDIC IMPLANTS MARKET, BY TYPE (THOUSAND UNITS), 2014-2022

TABLE 5. WORLD ORTHOPEDIC IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

TABLE 6. WORLD RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY REGION ($MILLION), 2014-2022

TABLE 7. WORLD SPINAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

TABLE 8. WORLD CARDIOVASCULAR IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

TABLE 9. WORLD INTRAOCULAR LENS MARKET, BY REGION ($MILLION), 2014-2022

TABLE 10. WORLD DENTAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

TABLE 11. WORLD BREAST IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

TABLE 12. WORLD OTHER IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

TABLE 13. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022

TABLE 14. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022

TABLE 15. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022

TABLE 16. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022

TABLE 17. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022

TABLE 18. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022

TABLE 19. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022

TABLE 20. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022

TABLE 21. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022

TABLE 22. ABBOTT: COMPANY SNAPSHOT

TABLE 23. ABBOTT: OPERATING SEGMENTS

TABLE 24. BIOTRONIK- COMPANY SNAPSHOT

TABLE 25. BIOTRONIK: OPERATING SEGMENTS

TABLE 26. BOSTON SCIENTIFIC: COMPANY SNAPSHOT

TABLE 27. C. R. BARD- COMPANY SNAPSHOT

TABLE 28. CARDINAL HEALTH- COMPANY SNAPSHOT

TABLE 29. CARDINAL HEALTH: OPERATING SEGMENTS

TABLE 30. CONMED - COMPANY SNAPSHOT

TABLE 31. CONMED - PRODUCT CATEGORY

TABLE 32. GLOBUS MEDICAL- COMPANY SNAPSHOT

TABLE 33. GLOBUS MEDICAL: PRODUCT CATEGORIES

TABLE 34. INTEGRA LIFESCIENCES - COMPANY SNAPSHOT

TABLE 35. INTEGRA LIFESCIENCES: PRODUCT CATEGORY

TABLE 36. J &J: COMPANY SNAPSHOT

TABLE 37. LIVANOVA: - COMPANY SNAPSHOT

TABLE 38. LIVANOVA: OPERATING SEGMENTS

TABLE 39. MEDTRONIC - COMPANY SNAPSHOT

TABLE 40. MEDTRONIC: OPERATING SEGMENTS

TABLE 41. NUVASIVE- COMPANY SNAPSHOT

TABLE 42. NUVASIVE- OPERATING SEGMENTS

TABLE 43. SMITH & NEPHEW - COMPANY SNAPSHOT

TABLE 44. ST. JUDE MEDICAL: COMPANY SNAPSHOT

TABLE 45. ST. JUDE MEDICAL: PRODUCT CATEGORIES

TABLE 46. INSTITUT STRAUMANN: COMPANY SNAPSHOT

TABLE 47. STRYKER - COMPANY SNAPSHOT

TABLE 48. ZIMMER BIOMET- COMPANY SNAPSHOT

List of Figures

FIGURE 1. IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION

FIGURE 2. TOP INVESTMENT POCKETS IN WORLD IMPLANTABLE MEDICAL DEVICES MARKET

FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)

FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE

FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES

FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES

FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES

FIGURE 8. PORTERS FIVE FORCES ANALYSIS

FIGURE 9. TOP PLAYER POSITIONING, 2015

FIGURE 10. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT ($MILLION), 2014-2022

FIGURE 11. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT (THOUSAND UNITS), 2014-2022

FIGURE 12. WORLD ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT ($MILLION), 2014-2022

FIGURE 13. WORLD ORTHOPEDIC IMPLANTS MARKET, BY TYPE (THOUSAND UNITS), 2014-2022

FIGURE 14. WORLD ORTHOPEDIC IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 15. RECONSTRUCTIVE JOINT REPLACEMENTS MARKET ($MILLION), 2014-2022

FIGURE 16. WORLD RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 17. SPINAL IMPLANTS MARKET ($MILLION), 2014-2022

FIGURE 18. WORLD SPINAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 19. WORLD CARDIOVASCULAR IMPLANTS MARKET ($MILLION), 2014-2022

FIGURE 20. WORLD CARDIOVASCULAR IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 21. WORLD INTRAOCULAR LENS MARKET ($MILLION), 2014-2022

FIGURE 22. WORLD INTRAOCULAR LENS MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 23. WORLD DENTAL IMPLANTS MARKET ($MILLION), 2014-2022

FIGURE 24. WORLD DENTAL IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 25. WORLD BREAST IMPLANTS MARKET ($MILLION), 2014-2022

FIGURE 26. WORLD BREAST IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 27. WORLD OTHER IMPLANTS MARKET ($MILLION), 2014-2022

FIGURE 28. WORLD OTHER IMPLANTS MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 29. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 30. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022

FIGURE 31. U.S. IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 32. CANADA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 33. MEXICO IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 34. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022

FIGURE 35. GERMANY IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 36. FRANCE IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 37. U.K. IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 38. REST OF EUROPE IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 39. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022

FIGURE 40. JAPAN IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 41. CHINA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 42. INDIA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 43. REST OF ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 44. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION ($MILLION), 2014-2022

FIGURE 45. LATIN AMERICA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 46. MIDDLE EAST IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 47. AFRICA IMPLANTABLE MEDICAL DEVICES MARKET ($MILLION), 2014-2022

FIGURE 48. ABBOTT: REVENUE ($MILLION), 2013-2015

FIGURE 49. ABBOTT: REVENUE, BY BUSINESS SEGMENT (%), 2015

FIGURE 50. ABBOTT: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 51. ABBOTT: SWOT ANALYSIS

FIGURE 52. BIOTRONIK- SWOT ANALYSIS

FIGURE 53. BOSTON SCIENTIFIC: REVENUE ($MILLION), 2013-2015

FIGURE 54. BOSTON SCIENTIFIC: REVENUE, BY BUSINESS SEGMENT (%), 2015

FIGURE 55. BOSTON SCIENTIFIC: REVENUE, BY SUBSEGMENT (%), 2015

FIGURE 56. BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 57. BOSTON SCIENTIFIC: SWOT ANALYSIS

FIGURE 58. C. R. BARD: REVENUE ($MILLION), 2013-2015

FIGURE 59. C. R. BARD: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015

FIGURE 60. C. R. BARD: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 61. C. R. BARD - SWOT ANALYSIS

FIGURE 62. CARDINAL HEALTH: REVENUE ($MILLION), 2013-2015

FIGURE 63. CARDINAL HEALTH: REVENUE, BY BUSINESS SEGMENT (%), 2015

FIGURE 64. CARDINAL HEALTH: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 65. CARDINAL HEALTH: SWOT ANALYSIS

FIGURE 66. CONMED: REVENUE ($MILLION), 2013-2015

FIGURE 67. CONMED: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015

FIGURE 68. CONMED: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 69. CONMED: SWOT ANALYSIS

FIGURE 70. GLOBUS MEDICAL: NET SALES ($MILLION), 2013-2015

FIGURE 71. GLOBUS MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY (%), 2015

FIGURE 72. GLOBUS MEDICAL: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 73. GLOBUS MEDICAL: SWOT ANALYSIS

FIGURE 74. INTEGRA LIFESCIENCES: REVENUE ($MILLION), 2013-2015

FIGURE 75. INTEGRA LIFESCIENCES: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015

FIGURE 76. INTEGRA LIFESCIENCES: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 77. INTEGRA LIFESCIENCES - SWOT ANALYSIS

FIGURE 78. J&J: REVENUE ($MILLION), 2013-2015

FIGURE 79. J&J: REVENUE, BY BUSINESS SEGMENT (%), 2015

FIGURE 80. J&J: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 81. J & J: SWOT ANALYSIS

FIGURE 82. LIVANOVA: NET SALES ($MILLION), 2013-2015

FIGURE 83. LIVANOVA: REVENUE, BY BUSINESS SEGMENT (%), 2015

FIGURE 84. LIVANOVA: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 85. LIVANOVA: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 86. LIVANOVA- SWOT ANALYSIS

FIGURE 87. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)

FIGURE 88. MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)

FIGURE 89. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)

FIGURE 90. MEDTRONIC: SWOT ANALYSIS

FIGURE 91. NUVASIVE: REVENUE ($MILLION), 2013-2015

FIGURE 92. NUVASIVE: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015

FIGURE 93. NUVASIVE: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 94. NUVASIVE: SWOT ANALYSIS

FIGURE 95. SMITH & NEPHEW: REVENUE ($MILLION), 2013-2015

FIGURE 96. SMITH & NEPHEW: REVENUE, BY PRODUCT TYPE (%), 2015

FIGURE 97. SMITH & NEPHEW: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 98. SMITH & NEPHEW: SWOT ANALYSIS

FIGURE 99. ST. JUDE MEDICAL: NET SALES ($MILLION), 2013-2015

FIGURE 100. ST. JUDE MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY (%), 2015

FIGURE 101. ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 102. ST. JUDE MEDICAL - SWOT ANALYSIS

FIGURE 103. STRAUMANN: REVENUE ($MILLION), 2013-2015

FIGURE 104. STRAUMANN: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 105. STRAUMANN: SWOT ANALYSIS

FIGURE 106. STRYKER: REVENUE ($MILLION), 2013-2015

FIGURE 107. STRYKER: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 108. STRYKER: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 109. STRYKER - SWOT ANALYSIS

FIGURE 110. WRIGHT- COMPANY SNAPSHOT

FIGURE 111. WRIGHT: REVENUE ($MILLION), 2013-2015

FIGURE 112. WRIGHT: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015

FIGURE 113. WRIGHT: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 114. WRIGHT- SWOT ANALYSIS

FIGURE 115. ZIMMER BIOMET: REVENUE ($MILLION), 2013-2015

FIGURE 116. ZIMMER BIOMET: REVENUE, BY PRODUCT TYPE CATEGORY (%), 2015

FIGURE 117. ZIMMER BIOMET: REVENUE, BY GEOGRAPHY (%), 2015

FIGURE 118. ZIMMER BIOMET- SWOT ANALYSIS

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370